0000950170-24-033514.txt : 20240319 0000950170-24-033514.hdr.sgml : 20240319 20240319162219 ACCESSION NUMBER: 0000950170-24-033514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240316 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgess Justin CENTRAL INDEX KEY: 0001812025 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 24763598 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION STREET 2: 2100 POWELL STREET, SUITE 1900 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 ownership.xml 4 X0508 4 2024-03-16 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001812025 Burgess Justin C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608 false true false false VP Finance & CAO false Stock Options (Right to Buy) 11.7 2024-03-16 4 A false 20000 0 A 2031-03-16 Common Stock 20000 20000 D This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of March 16, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. /s/ JUSTIN BURGESS 2024-03-19